PME-1 is a protein that modifies other proteins by removing methyl groups, but high levels of PME-1 are observed in some diseases, including Alzheimer's disease (AD) and cancer.

Scientists have identified mutated immune cell clones that could point to improved treatment for refractory celiac disease.

A baby born with a rare and dangerous genetic disease is thriving after getting an experimental gene editing treatment made ...

Weill Cornell Medicine's AI-based approach accurately groups cancer patients, improving treatment predictions and clinical ...

University of Dundee scientists have discovered a new target that could herald the development of new drugs to treat ...

The authors confirm that telomeres in telomerase-positive cells terminate with 5'-ATC in a Pot1-dependent manner, and demonstrate that this principle holds true in telomerase-negative ALT cells as ...